These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9815692)

  • 1. Adenoviral vectors efficiently target cell lines derived from selected lymphocytic malignancies, including anaplastic large cell lymphoma and Hodgkin's disease.
    Meeker TC; Lay LT; Wroblewski JM; Turturro F; Li Z; Seth P
    Clin Cancer Res; 1997 Mar; 3(3):357-64. PubMed ID: 9815692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
    Wildner O; Hoffmann D; Jogler C; Uberla K
    Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus.
    Wroblewski JM; Lay LT; Van Zant G; Phillips G; Seth P; Curiel D; Meeker TC
    Cancer Gene Ther; 1996; 3(4):257-64. PubMed ID: 8853551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.
    Hasegawa Y; Nishiyama Y; Imaizumi K; Ono N; Kinoshita T; Hatano S; Saito H; Shimokata K
    Cancer Gene Ther; 2000 Apr; 7(4):557-62. PubMed ID: 10811473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors.
    Brand K; Arnold W; Bartels T; Lieber A; Kay MA; Strauss M; Dörken B
    Cancer Gene Ther; 1997; 4(1):9-16. PubMed ID: 9012446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy.
    Ketola A; Määttä AM; Pasanen T; Tulimäki K; Wahlfors J
    Int J Mol Med; 2004 May; 13(5):705-10. PubMed ID: 15067374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
    Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
    Mizuno M; Ryuke Y; Yoshida J
    Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
    Morris JC; Wildner O
    Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses.
    Wildner O; Morris JC
    J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hCAR-EGFP fusion receptor in human follicular lymphoma B cells - a model for adenoviral gene therapy for B cell malignancies.
    Mättö M; Nuutinen UM; Hakkarainen T; Tallone T; Wahlfors J; Pelkonen J
    Int J Mol Med; 2006 Jun; 17(6):1057-62. PubMed ID: 16685416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection.
    Buttgereit P; Weineck S; Röpke G; Märten A; Brand K; Heinicke T; Caselmann WH; Huhn D; Schmidt-Wolf IG
    Cancer Gene Ther; 2000 Aug; 7(8):1145-55. PubMed ID: 10975675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.
    Loimas S; Toppinen MR; Visakorpi T; Jänne J; Wahlfors J
    Cancer Gene Ther; 2001 Feb; 8(2):137-44. PubMed ID: 11263529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.